Collagen XVIII-derived endostatin [118] and perlecan-cleaved endorepellin [119], strongly inhibit tumor growth in many preclinical cancer models and show angiogenesis-blocking effects on sprouting ECs [117]. The gene discussed is HSPG2; the disease is neoplasm.